Alerts will be sent to your verified email
Verify Email
DRAGARWQ
|
Dr Agarwals Eye Hsp
|
Apollo Hospital Ent.
|
Max Healthcare Inst
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
22.93 % | 12.37 % | 9.23 % |
|
5yr average Equity Multiplier
|
3.49 | 2.85 | 1.48 |
|
5yr Average Asset Turnover Ratio
|
0.74 | 0.96 | 0.42 |
|
5yr Avg Net Profit Margin
|
9.4 % | 4.46 % | 13.79 % |
|
Price to Book
|
9.93 | 12.86 | 12.92 |
|
P/E
|
38.09 | 73.03 | 112.67 |
|
5yr Avg Cash Conversion Cycle
|
-294.79 Days | -26.12 Days | -143.35 Days |
|
Inventory Days
|
11.83 Days | 12.83 Days | 5.36 Days |
|
Days Receivable
|
13.17 Days | 45.47 Days | 29.86 Days |
|
Days Payable
|
315.05 Days | 68.55 Days | 185.68 Days |
|
5yr Average Interest Coverage Ratio
|
5.25 | 3.39 | 11.19 |
|
5yr Avg ROCE
|
17.28 % | 10.86 % | 10.55 % |
|
5yr Avg Operating Profit Margin
|
26.87 % | 12.91 % | 23.93 % |
|
5 yr average Debt to Equity
|
0.37 | 0.61 | 0.15 |
|
5yr CAGR Net Profit
|
27.65 % | 14.59 % | n/a |
|
5yr Average Return on Assets
|
6.39 % | 4.4 % | 6.36 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.9 % | 29.34 % | 23.74 % |
|
Share Pledged by Promoters
|
55.45 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.1 % | 0.01 % | -26.9 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.12 % | 8.3 % | -6.67 % |
|
Dr Agarwals Eye Hsp
|
Apollo Hospital Ent.
|
Max Healthcare Inst
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
Therapeutic Area Wise Break-Up - Domestic
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|